113 related articles for article (PubMed ID: 2979255)
1. Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
Thomson AB; McCullough HN; Kirdeikis P; Zuk L; Simpson I; Cook DJ; Wildeman RA; Brunet K; Fisher D; Pinchbeck B
Aliment Pharmacol Ther; 1988 Aug; 2(4):325-36. PubMed ID: 2979255
[TBL] [Abstract][Full Text] [Related]
2. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
[TBL] [Abstract][Full Text] [Related]
3. Alpha chain unsaturated derivatives of misoprostol.
Collins PW; Gasiecki AF; Weier RM; Kramer SW; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
Prostaglandins; 1987; 33 Suppl():17-28. PubMed ID: 3122273
[TBL] [Abstract][Full Text] [Related]
4. Perspective on the gastric antisecretory effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
[TBL] [Abstract][Full Text] [Related]
5. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
Davis GR; Fordtran JS; Dajani EZ
Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
7. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
8. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
Dammann HG; Rehner M; Walter TA; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
[TBL] [Abstract][Full Text] [Related]
9. 18-cycloalkyl analogues of enisoprost.
Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
[TBL] [Abstract][Full Text] [Related]
10. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
Silverstein FE; Kimmey MB; Saunders DR; Levine DS
Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
[TBL] [Abstract][Full Text] [Related]
11. Does misoprostol given as a single large dose improve its antisecretory effect?
Chiverton SG; Burget DW; Salena BJ; Hunt RH
Aliment Pharmacol Ther; 1989 Aug; 3(4):403-7. PubMed ID: 2518855
[TBL] [Abstract][Full Text] [Related]
12. Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine.
Salmon PR; Barton T
Dig Dis Sci; 1986 Feb; 31(2 Suppl):55S-62S. PubMed ID: 3080289
[TBL] [Abstract][Full Text] [Related]
13. Effects of misoprostol on gastric acid and mucus secretion in man.
Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and gastrointestinal pharmacology of the 4-fluoro analogue of enisoprost.
Collins PW; Kramer SW; Gullikson GW
J Med Chem; 1987 Nov; 30(11):1952-5. PubMed ID: 3669004
[TBL] [Abstract][Full Text] [Related]
15. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
Bertaccini G; Adami M; Coruzzi G
Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
Peghini PL; Katz PO; Castell DO
Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
[TBL] [Abstract][Full Text] [Related]
18. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring.
Savarino V; Scalabrini P; Mela GS; di Timoteo E; Percario G; Magnolia MR; Celle G
Dig Dis Sci; 1988 Mar; 33(3):293-7. PubMed ID: 3125025
[TBL] [Abstract][Full Text] [Related]
20. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
